Evidence map›Paper›PMID 35223757›Full record

ArticleFrontiers in public health

The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden.

Rachel D Eckford, Andrea Gaisser, Volker Arndt, Michael Baumann, Evelyn Kludt, Katja Mehlis, Jasper Ubels, Eva C Winkler, Susanne Weg-Remers, Michael Schlander

Abstract read
In one paragraph

Article in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Impact of the COVID-19 pandemic on oncological care in Germany: rapid review.Journal of cancer research and clinical oncology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rachel D EckfordDivision of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andrea GaisserGerman Cancer Information Service, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Volker ArndtUnit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael BaumannGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Evelyn KludtGerman Cancer Information Service, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katja MehlisDepartment of Medical Oncology, Section of Translational Medical Ethics, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Jasper UbelsDivision of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Eva C WinklerDepartment of Medical Oncology, Section of Translational Medical Ethics, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Susanne Weg-RemersGerman Cancer Information Service, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael SchlanderDivision of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, governments imposed various measures to decrease the rate of disease spread, and health care policy makers prioritized resource allocation to accommodate COVID-19 patients. We conducted a cross-sectional online survey in Germany (July 2020-June 2021) to assess the frequency of changes to cancer care among cancer patients and to explore the psychological impact of the pandemic writ large. Cancer patients who contacted the Cancer Information Service (Krebsinformationsdienst, KID) of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) via email were invited to complete an online questionnaire, capturing demographics, cancer specifics (e.g., type, disease phase, primary place of treatment, etc.), and any changes to their medical, follow-up, psycho-oncological or nursing care. General level of psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS) along with face-validated items regarding worries and social isolation specific to the pandemic. In total, 13% of 621 patients reported a change to their treatment or care plan. Of those patients with changes, the majority of changes were made to follow-up care after treatment (56%), to monitoring during treatment (29%) and to psychological counseling (20%). Of the overall sample, more than half of patients (55%) reported symptoms of anxiety and 39% reported symptoms of depression. Patients with a change in cancer care were more likely to report symptoms of depression than those with no change (AOR: 2.18; 95% CI: 1.26-3.76). Concern about the pandemic affecting the quality of health care was a predictor of both anxiety (AOR: 2.76; 95% CI: 1.75-4.35) and depression (AOR: 2.15; 95% CI: 1.43-3.23). Results showed that the majority of cancer patients in our study did not experience a change in their cancer care. However, the level of anxiety and psycho-social burden of cancer patients during the pandemic was high throughout the study period. Our findings underscore the need for health care services and policy makers to assess and to attend cancer patients' medical needs, with added emphasis on patients' psychological and social well-being. This applies particularly in situations where the healthcare system is strained and prioritization is necessary.

Indexed as

COVID-19NeoplasmsAftercareCross-Sectional StudiesDepressionGermanyHumansPandemicsSARS-CoV-2anxietycancer carechanges in treatmentCOVID-19depressionhealth care management

Identifiers

PMID35223757
PMCPMC8865576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.